These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38247096)

  • 1. [Long-Term Survival after Liver and Pulmonary Metastasectomy Following Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma-A Case Report].
    Aizawa K; Takizawa K; Kawachi Y; Abe S; Ando T; Hirose Y; Ishikawa H; Sakata J; Muneoka Y; Kano Y; Tajima Y; Ichikawa H; Nakano M; Shimada Y; Wakai T
    Gan To Kagaku Ryoho; 2024 Jan; 51(1):72-74. PubMed ID: 38247096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-Term Survival after Multidisciplinary Treatment for Resected Pancreatic Adenocarcinoma with Recurrence of Pulmonary Metastases - A Case Report].
    Tsukamoto T; Takahama M; Kodai S; Kanazawa A; Hori T; Kaizaki R; Takatsuka S; Komatsu R
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1883-1885. PubMed ID: 29394808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pancreatic Cancer with Liver Metastasis Treated with Radical Surgery after Chemotherapy].
    Katsura Y; Takeda Y; Ohmura Y; Sakamoto T; Inatome J; Naito A; Murakami K; Kagawa Y; Takeno A; Egawa C; Kato T; Tamura S
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1975-1977. PubMed ID: 28133194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of metachronous oligo-hepatic and peritoneal metastases of pancreatic cancer with a favorable outcome after conversion surgery combined with perioperative sequential chemotherapy.
    Tohyama T; Tanno Y; Murakami T; Hayashi T; Fujimoto Y; Takehara K; Seshimo K; Fukuhara R; Omori M; Matsumoto T
    Clin J Gastroenterol; 2024 Apr; 17(2):371-381. PubMed ID: 38291249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
    Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V;
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Searching for novel multimodal treatments in oligometastatic pancreatic cancer.
    Filippini DM; Grassi E; Palloni A; Carloni R; Casadei R; Ricci C; Serra C; Ercolani G; Brandi G; Di Marco M
    BMC Cancer; 2020 Mar; 20(1):271. PubMed ID: 32228504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with gemcitabine and nab-paclitaxel for a metastatic pancreatic ductal adenocarcinoma patient undergoing hemodialysis.
    Kaneko T; Sugimori K; Tozuka Y; Fukushima T; Okada K; Oka H; Okazaki H; Maeda S
    Clin J Gastroenterol; 2019 Oct; 12(5):484-489. PubMed ID: 30993653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laparoscopic Liver Resection for Liver Metastasis from Unresectable Pancreatic Ductal Adenocarcinoma Well-Controlled by Chemotherapy-A Case Report].
    Nobori C; Tsukamoto T; Nishiyama T; Kunimoto T; Kaizaki R; Inoue T; Nishiguchi Y
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1881-1883. PubMed ID: 33468860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX.
    Tanaka M; Heckler M; Mihaljevic AL; Sun H; Klaiber U; Heger U; Büchler MW; Hackert T
    Eur J Surg Oncol; 2019 Aug; 45(8):1453-1459. PubMed ID: 30981446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of successful management of liver metastases of pancreatic carcinoma by hepatectomy and adjuvant chemotherapy].
    Fujisaki S; Takashina M; Sakurai K; Tomita R; Takayama T
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2109-11. PubMed ID: 19106539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival following hepatectomy, radiation, and chemotherapy for recurrent pancreatic carcinoma: a case report.
    Fujisaki S; Takashina M; Tomita R; Sakurai K; Takayama T
    World J Surg Oncol; 2017 Aug; 15(1):157. PubMed ID: 28835248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nab-Paclitaxel plus Gemcitabine for Metastatic Pancreatic Cancer].
    Katsura Y; Takeda Y; Ohmura Y; Motoyama Y; Ishida T; Morimoto Y; Matsushita K; Naito A; Murakami K; Kagawa Y; Okishiro M; Takeno A; Egawa C; Kato T; Tamura S
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2367-9. PubMed ID: 26805366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial.
    Bachet JB; Hammel P; Desramé J; Meurisse A; Chibaudel B; André T; Debourdeau P; Dauba J; Lecomte T; Seitz JF; Tournigand C; Aparicio T; Meyer VG; Taieb J; Volet J; Monier A; Bonnetain F; Louvet C
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):337-346. PubMed ID: 28397697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver metastases from gastric carcinoma: A Case report and review of the literature.
    Polkowska-Pruszyńska B; Rawicz-Pruszyński K; Ciseł B; Sitarz R; Polkowska G; Krupski W; Polkowski WP
    Curr Probl Cancer; 2017; 41(3):222-230. PubMed ID: 28625333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].
    Sugimoto K; Okada K; Nakahira S; Okamura S; Miki H; Nakata K; Suzuki R; Yoshimura M; Uji K; Yoshida A; Tamura S
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):321-3. PubMed ID: 19223756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.
    Perri G; Prakash L; Qiao W; Varadhachary GR; Wolff R; Fogelman D; Overman M; Pant S; Javle M; Koay EJ; Herman J; Kim M; Ikoma N; Tzeng CW; Lee JE; Katz MHG
    JAMA Surg; 2020 Sep; 155(9):832-839. PubMed ID: 32667641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma.
    Klein-Brill A; Amar-Farkash S; Lawrence G; Collisson EA; Aran D
    JAMA Netw Open; 2022 Jun; 5(6):e2216199. PubMed ID: 35675073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Case of Long-Term Survival after Resection of Pancreatic Ductal Adenocarcinoma with Para-Aortic Lymph Node Metastasis].
    Otake H; Takizawa K; Nagaro H; Toge K; Hirose Y; Ishikawa H; Miura K; Ichikawa H; Hanyu T; Nagahashi M; Shimada Y; Ishikawa T; Sakata J; Kobayashi T; Wakai T
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2002-2004. PubMed ID: 35045474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of pancreatic cancer with distant metastasis successfully resected after neoadjuvant chemotherapy with a combination of S-1 and gemcitabine].
    Maeda T; Tsuchiya M; Ishii J; Koda T; Kubota Y; Katagiri T; Tamura A; Otsuka Y; Shibuya K; Kaneko H
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2184-6. PubMed ID: 25731464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection.
    Schneitler S; Kröpil P; Riemer J; Antoch G; Knoefel WT; Häussinger D; Graf D
    World J Gastroenterol; 2015 May; 21(20):6384-90. PubMed ID: 26034375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.